Chemainus-based Mark Syme and a small team at Biopreme Medical Technologies have spent the past decade redesigning the traditional hypodermic needle to deliver less pain with its poke.
To reduce pain while effectively delivering medication, a needle should reach an optimal subcutaneous depth of three millimetres in a stabilized injection site. Working backwards from this protocol, Syme and Dr. Aleksandr Kavokin, a Yale-trained physician based in Russia, designed a suction tube controlled by a squeeze bulb that draws the flesh gently toward a hidden micro-needle.
“We went into the customer discovery process with open eyes,” says Syme. “We realized that a very viable niche [for] pediatric applications would be something to focus on.”
With support from famous U.S. physician Patch Adams and mid-Island tech organization Innovation Island, Biopreme has raised $200,000 in grassroots funding and is working with StarFish Medical to bring the Effi-Q syringe adaptor to market. Though a release date and price are pending, Syme says each adaptor will be sold for less than a dollar.
Added benefits of the new design include improved safety for medical personnel through a lowered risk of needle prick incidents and blood spatter.
This article is from the August/September 2018 issue of Douglas.